Abstract:MicroRNAs (miRNAs or miRs), including miR-34a, have been shown to regulate nuclear receptor, drug-metabolizing enzyme, and transporter gene expression in various cell model systems. However, to what degree miRNAs affect pharmacokinetics (PK) at the systemic level remains unknown. In addition, miR-34a replacement therapy represents a new cancer treatment strategy, although it is unknown whether miR-34a therapeutic agents could elicit any drug–drug interactions. To address this question, we refined a practical single-mouse PK approach and investigated the effects of a bioengineered miR-34a agent on the PK of several cytochrome P450 probe drugs (midazolam, dextromethorphan, phenacetin, diclofenac, and chlorzoxazone) administered as a cocktail. This approach involves manual serial blood microsampling from a single mouse and requires a sensitive liquid chromatography–tandem mass spectrometry assay, which was able to illustrate the sharp changes in midazolam PK by ketoconazole and pregnenolone 16α-carbonitrile as well as phenacetin PK by α-naphthoflavone and 3-methylcholanthrene. Surprisingly, 3-methylcholanthrene also decreased systemic exposure to midazolam, whereas both pregnenolone 16α-carbonitrile and 3-methylcholanthrene largely reduced the exposure to dextromethorphan, diclofenac, and chlorzoxazone. Finally, the biologic miR-34a agent had no significant effects on the PK of cocktail drugs but caused a marginal (45%–48%) increase in systemic exposure to midazolam, phenacetin, and dextromethorphan in mice. In vitro validation of these data suggested that miR-34a slightly attenuated intrinsic clearance of dextromethorphan. These findings from single-mouse PK and corresponding mouse liver microsome models suggest that miR-34a might have minor or no effects on the PK of coadministered cytochrome P450–metabolized drugs.

The Effects of Microrna on the Absorption, Distribution, Metabolism and Excretion of Drugs

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms Behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

The Effect of Micrornas in the Regulation of Human CYP3A4: a Systematic Study Using a Mathematical Model.

MiRNAs and Mirna Polymorphisms Modify Drug Response

MiRNA and interindividual difference in drug response

Research status of microRNA mediated drug regulation of transporter and metabolizing enzymes

Post-transcription regulation of drug metabolic enzymes by miRNAs

Bioengineered Mir-27B-3p and Mir-328-3p Modulate Drug Metabolism and Disposition Via the Regulation of Target ADME Gene Expression.

Impact of Individual Factors on DNA Methylation of ADME Genes: A Systematic Review

Function of Micrornas in Development of Immune System and in Regulation of Immune Response

An Integrating Approach for Genome-Wide Screening of MicroRNA Polymorphisms Mediated Drug Response Alterations

The Roles of Micrornas in Epigenetic Regulation.

Effects of Microrna-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice

Small Molecules with Big Roles in Microrna Chemical Biology and Microrna-Targeted Therapeutics

DNA Methylation and Personalized Medicine.

The Role of Micrornas in Toxicology

Current Research in Drug Effects and Drug Discovery of DNA Methylation

Impact of individual factors on DNA methylation of drug metabolism genes: A systematic review

Recent advances in methylation modifications of microRNA

Research status of microRNA-dependent control of drug metabolic enzymes and transporters mediated by nuclear receptors